June 2017 | Invited Presentations

Best Initial Treatment Strategies for EGFR-Mutant Lung Cancer

June 01, 2017

This review will focus on current therapies used in the first-line setting for advanced EGFR mutation positive non–small cell lung cancer (NSCLC) followed by emerging data that may lead to a transition in the choice for initial therapy in these patients.

x